BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

433 related articles for article (PubMed ID: 16178850)

  • 1. Clinical uses of intravenous immunoglobulin.
    Jolles S; Sewell WA; Misbah SA
    Clin Exp Immunol; 2005 Oct; 142(1):1-11. PubMed ID: 16178850
    [No Abstract]   [Full Text] [Related]  

  • 2. Supply, use, and abuse of intravenous immunoglobulin.
    Nowak-Wegrzyn A; Lederman HM
    Curr Opin Pediatr; 1999 Dec; 11(6):533-9. PubMed ID: 10590912
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intravenous immunoglobulin in autoimmune and inflammatory diseases: more than mere transfer of antibodies.
    Sibéril S; Elluru S; Negi VS; Ephrem A; Misra N; Delignat S; Bayary J; Lacroix-Desmazes S; Kazatchkine MD; Kaveri SV
    Transfus Apher Sci; 2007 Aug; 37(1):103-7. PubMed ID: 17765663
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Intravenous immunoglobulins in dermatology].
    Nydegger U; Hunziker T
    Ann Dermatol Venereol; 2002; 129(8-9):1078-81. PubMed ID: 12442118
    [No Abstract]   [Full Text] [Related]  

  • 5. The role of intravenous immunoglobulins in pediatric diseases.
    Ramasubramanian KV; Kumar A; Kabra SK; Seth V
    Indian Pediatr; 1999 Jan; 36(1):51-63. PubMed ID: 10709123
    [No Abstract]   [Full Text] [Related]  

  • 6. 7th International Immunoglobulin Conference: Mechanisms of action.
    Basta M; Branch DR
    Clin Exp Immunol; 2014 Dec; 178 Suppl 1(Suppl 1):87-8. PubMed ID: 25546774
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immune supplementation and immune modulation with intravenous immunoglobulin.
    Mazer BD; Al-Tamemi S; Yu JW; Hamid Q
    J Allergy Clin Immunol; 2005 Oct; 116(4):941-4. PubMed ID: 16210080
    [No Abstract]   [Full Text] [Related]  

  • 8. Immunoglobulins and their use in children.
    Łaguna P; Gołębiowska-Staroszczyk S; Trzaska M; Grabarczyk M; Matysiak M
    Adv Clin Exp Med; 2015; 24(1):153-9. PubMed ID: 25923100
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intravenous immune globulin use in children. Infectious Diseases and Immunization Committee, Canadian Paediatric Society.
    CMAJ; 1992 Jan; 146(2):121-4. PubMed ID: 1735037
    [No Abstract]   [Full Text] [Related]  

  • 10. [Functional mechanisms of intravenous immunoglobulins].
    Lories RJ; Blockmans D
    Acta Clin Belg; 1998 Dec; 53(6):360-6. PubMed ID: 10023145
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ASHP therapeutic guidelines for intravenous immune globulin. ASHP Commission on Therapeutics.
    Clin Pharm; 1992 Feb; 11(2):117-36. PubMed ID: 1312920
    [No Abstract]   [Full Text] [Related]  

  • 12. [Practical comments on the use of immunoglobulins].
    Lewandowicz-Uszyńska A; Swierkot J
    Pol Merkur Lekarski; 2011 Jun; 30(180):448-51. PubMed ID: 21751557
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intravenous gammaglobulin, 2: Pharmacology, clinical uses and mechanisms of action.
    Schiff RI
    Pediatr Allergy Immunol; 1994 Aug; 5(3):127-56. PubMed ID: 7951755
    [No Abstract]   [Full Text] [Related]  

  • 14. Intravenous immune globulin in autoimmune and inflammatory diseases.
    Gelfand EW
    N Engl J Med; 2012 Nov; 367(21):2015-25. PubMed ID: 23171098
    [No Abstract]   [Full Text] [Related]  

  • 15. Both patient characteristics and IVIG product-specific mechanisms may affect eosinophils in immunoglobulin-treated Kawasaki disease.
    Khan S; Doré PC; Sewell WA
    Pediatr Allergy Immunol; 2008 Mar; 19(2):186-7. PubMed ID: 18257907
    [No Abstract]   [Full Text] [Related]  

  • 16. [Old and current aspects of intravenous immunoglobulin therapy].
    Nydegger U
    Schweiz Med Wochenschr; 1994 Jan; 124(1-2):5-25. PubMed ID: 8296191
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of toxic epidermal necrolysis with intravenous immunoglobulin.
    Simeone F; Rubio ER
    J La State Med Soc; 2003; 155(5):266-9. PubMed ID: 14748489
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel mechanism for therapeutic action of IVIg in autoimmune blistering dermatoses.
    Michael D; Grando SA
    Curr Dir Autoimmun; 2008; 10():333-43. PubMed ID: 18460894
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Toxic epidermal necrolysis treated with intravenous immunoglobulin and granulocyte colony-stimulating factor.
    Kalyoncu M; Cimsit G; Cakir M; Okten A
    Indian Pediatr; 2004 Apr; 41(4):392-5. PubMed ID: 15123870
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Is intravenous administration of immunoglobulins a first-choice method in autoimmune diseases?].
    Vermeulen M
    Ned Tijdschr Geneeskd; 1993 Sep; 137(39):1955-8. PubMed ID: 8413702
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 22.